SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 227 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $3,114,000 | -10.0% | 149,430 | +2.5% | 0.03% | +3.1% |
| Q2 2020 | $3,460,000 | +58.1% | 145,725 | +19.8% | 0.03% | +60.0% |
| Q1 2020 | $2,189,000 | -42.8% | 121,688 | -24.6% | 0.02% | -13.0% |
| Q4 2019 | $3,826,000 | +96.8% | 161,313 | +128.0% | 0.02% | +109.1% |
| Q3 2019 | $1,944,000 | -35.1% | 70,746 | -21.8% | 0.01% | -31.2% |
| Q2 2019 | $2,995,000 | +1.5% | 90,522 | +7.5% | 0.02% | +6.7% |
| Q1 2019 | $2,952,000 | +708.8% | 84,236 | +1061.7% | 0.02% | +650.0% |
| Q3 2018 | $365,000 | -14.1% | 7,251 | +2.2% | 0.00% | 0.0% |
| Q2 2018 | $425,000 | – | 7,093 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
| ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
| S&T BANK/PA | 223,775 | $8,107 | 1.46% |
| Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
| Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
| Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
| Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
| Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |